Document is current
Any future updates will be listed below
-
Authors
Englund, Amir https://orcid.org/0000-0002-2478-209X
Oliver, Dominic https://orcid.org/0000-0002-8920-3407
Chesney, Edward https://orcid.org/0000-0003-2851-5252
Chester, Lucy
Wilson, Jack https://orcid.org/0000-0002-2732-1731
Sovi, Simina
De Micheli, Andrea
Hodsoll, John
Fusar-Poli, Paolo
Strang, John
Murray, Robin M. https://orcid.org/0000-0003-0829-0519
Freeman, Tom P.
McGuire, Philip https://orcid.org/0000-0003-4381-0532
- License Information
-
More Information
Article History
Received: 23 June 2022
Revised: 5 October 2022
Accepted: 10 October 2022
First Online: 16 November 2022
Competing interests
: AE has received speakers’ honoraria from GW Pharmaceuticals. RMM has received speakers’ honoraria from Lundbeck, Sunovian, Otsuka, and Janssen. JS has undertaken research supported financially by various pharmaceutical companies, but this has not involved studies of cannabis or cannabis-related products. All remaining authors report no conflicting interests.
